Two of America’s leading medical and pharmaceutical researchers, Chicago Clinical Research Institute, Inc. (CCRII) and Regeneron, have made highly positive findings in their recent clinical trial of a new SARS-CoV-2 prophylaxis. Go to https://ccrii.us to find out more.

document preview